Zegerid 20mg-1680mg Powder Packets

Manufacturer BAUSCH HEALTH Active Ingredient Omeprazole and Sodium Bicarbonate Powder Packets(oh MEP ra zole & SOW dee um bye KAR bun ate) Pronunciation oh MEP ra zole & SOW dee um bye KAR bun ate
It is used to treat gastroesophageal reflux disease (GERD; acid reflux).It is used to treat heartburn.It is used to treat GI (gastrointestinal) ulcers.It is used to treat or prevent ulcers of the esophagus.It is used to prevent GI (gastrointestinal) bleeding in some patients.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Proton Pump Inhibitor (PPI) / Antacid Combination
đŸ§Ŧ
Pharmacologic Class
Gastric Acid Secretion Inhibitor / Antacid
🤰
Pregnancy Category
Not available
✅
FDA Approved
Jun 2004
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Zegerid is a medicine that combines two ingredients: omeprazole and sodium bicarbonate. Omeprazole works by reducing the amount of acid your stomach makes, which helps heal acid-related damage and relieve symptoms like heartburn. Sodium bicarbonate is an antacid that quickly neutralizes stomach acid and also helps the omeprazole work better by protecting it from stomach acid.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take this medication at least 1 hour before a meal. To prepare, mix the powder with 1 or 2 teaspoons (5 or 10 mL) of water in a cup, and then drink. Do not use any liquid other than water. After mixing, rinse the cup with more water and drink the rinse water. It is essential to take your dose immediately after mixing and not store it for future use.

If you have a feeding tube, you can also use the powder after mixing. However, you must stop feeding 3 hours before and 1 hour after administering this medication. Before and after giving this medication, flush your feeding tube.

Before taking antacids with this medication, consult your doctor. Continue taking this medication as directed by your doctor or healthcare provider, even if you feel well. If your dosage is increased, do not take two capsules of a lower dose to achieve the higher dose, as this will result in excessive sodium bicarbonate intake.

Storing and Disposing of Your Medication

Store this medication at room temperature, protected from light, and in a dry place. Do not store it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of medications, consult your pharmacist, as there may be drug take-back programs available in your area.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Take Zegerid on an empty stomach, at least 30-60 minutes before your first meal of the day.
  • Mix the powder packet contents with 1-2 tablespoons of water. Stir well and drink immediately. Do not chew or crush the granules.
  • Do not take with other liquids or food.
  • Avoid lying down for at least 3 hours after eating, especially before bedtime.
  • Elevate the head of your bed if you experience nighttime heartburn.
  • Avoid trigger foods and drinks that worsen your symptoms (e.g., spicy foods, fatty foods, caffeine, alcohol, citrus, chocolate, peppermint).
  • Maintain a healthy weight.
  • Quit smoking, as it can worsen acid reflux.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 20 mg omeprazole / 1680 mg sodium bicarbonate once daily, 30-60 minutes before a meal.
Dose Range: 20 - 40 mg

Condition-Specific Dosing:

Erosive Esophagitis: 20 mg or 40 mg omeprazole / 1680 mg sodium bicarbonate once daily for 4-8 weeks. Maintenance: 20 mg once daily.
GERD (Symptomatic): 20 mg omeprazole / 1680 mg sodium bicarbonate once daily for up to 4 weeks.
Duodenal Ulcer: 20 mg omeprazole / 1680 mg sodium bicarbonate once daily for 4 weeks.
Gastric Ulcer: 40 mg omeprazole / 1680 mg sodium bicarbonate once daily for 4-8 weeks.
Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome): Initial: 60 mg omeprazole / 1680 mg sodium bicarbonate once daily. Doses up to 360 mg/day have been administered. Doses >80 mg/day should be divided.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Safety and efficacy not established in pediatric patients <18 years of age for Zegerid Powder Packets).
Adolescent: Not established (Safety and efficacy not established in pediatric patients <18 years of age for Zegerid Powder Packets).
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment generally needed.
Moderate: No dosage adjustment generally needed.
Severe: No dosage adjustment generally needed for omeprazole. However, sodium bicarbonate should be used with caution in severe renal impairment due to risk of metabolic alkalosis and fluid overload.
Dialysis: Omeprazole is not significantly removed by hemodialysis. Sodium bicarbonate should be used with caution due to risk of metabolic alkalosis and fluid overload.

Hepatic Impairment:

Mild: No dosage adjustment generally needed.
Moderate: Consider dose reduction for omeprazole (e.g., 20 mg daily) in patients with severe hepatic impairment (Child-Pugh Class C).
Severe: Consider dose reduction for omeprazole (e.g., 20 mg daily) in patients with severe hepatic impairment (Child-Pugh Class C).

Pharmacology

đŸ”Ŧ

Mechanism of Action

Omeprazole is a proton pump inhibitor (PPI) that irreversibly binds to and inhibits the H+/K+-ATPase (proton pump) in the secretory canaliculi of the parietal cells, thereby blocking the final step in gastric acid production. Sodium bicarbonate is an antacid that neutralizes gastric acid and also protects omeprazole from acid degradation in the stomach, allowing for its absorption.
📊

Pharmacokinetics

Absorption:

Bioavailability: Omeprazole: Approximately 30-40% (increases with repeated dosing). Sodium bicarbonate: Rapidly absorbed.
Tmax: Omeprazole: 0.5-3.5 hours (with sodium bicarbonate). Sodium bicarbonate: Immediate.
FoodEffect: Should be taken on an empty stomach, at least 30-60 minutes before a meal, for optimal absorption of omeprazole.

Distribution:

Vd: Omeprazole: 0.3 L/kg
ProteinBinding: Omeprazole: Approximately 95%
CnssPenetration: Limited

Elimination:

HalfLife: Omeprazole: Approximately 1 hour (terminal half-life is prolonged in hepatic impairment). Sodium bicarbonate: Not applicable (eliminated via renal excretion of bicarbonate and CO2 via lungs).
Clearance: Omeprazole: Approximately 500-600 mL/min
ExcretionRoute: Omeprazole: Primarily renal (approximately 80%) and biliary/fecal (approximately 20%). Sodium bicarbonate: Renal (as bicarbonate) and respiratory (as CO2).
Unchanged: Omeprazole: <0.1% in urine
âąī¸

Pharmacodynamics

OnsetOfAction: Acid neutralization by sodium bicarbonate: Immediate. Acid suppression by omeprazole: Within 1 hour.
PeakEffect: Acid suppression by omeprazole: 2 hours.
DurationOfAction: Acid suppression by omeprazole: Up to 72 hours (due to irreversible binding). Acid neutralization by sodium bicarbonate: Short-lived (minutes to hours).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Allergic Reaction: Rash, hives, itching, red, swollen, blistered, or peeling skin with or without fever, wheezing, tightness in the chest or throat, trouble breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat.
Electrolyte Imbalance: Mood changes, confusion, muscle pain, cramps, or spasms, weakness, shakiness, change in balance, abnormal heartbeat, seizures, loss of appetite, or severe upset stomach or vomiting.
Kidney Problems: Inability to pass urine, change in urine output, blood in the urine, or sudden weight gain.
High Blood Sugar: Confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath.
Pancreatitis: Severe stomach pain, severe back pain, or severe upset stomach or vomiting.
Liver Problems: Dark urine, fatigue, decreased appetite, upset stomach or stomach pain, light-colored stools, vomiting, or yellow skin or eyes.
High or Low Blood Pressure: Severe headache or dizziness, fainting, or changes in vision. Confusion, shakiness, dizziness, or fainting. Twitching, burning, numbness, or tingling sensations. Bone pain. Fever, chills, or sore throat, unexplained bruising or bleeding, or feeling extremely tired or weak. Swelling or weight gain.

Additional Serious Side Effects:

C. diff-associated Diarrhea (CDAD): Stomach pain or cramps, watery or bloody stools. Do not treat diarrhea without consulting your doctor.
Vitamin B-12 Deficiency: Shortness of breath, dizziness, abnormal heartbeat, muscle weakness, pale skin, fatigue, mood changes, or numbness or tingling in the arms or legs. This can occur with long-term treatment (over 3 years).
Lupus: Rash on the cheeks or other body parts, skin color changes, easy sunburning, muscle or joint pain, chest pain or shortness of breath, or swelling in the arms or legs. If you have lupus, inform your doctor.
Severe Skin Reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions. These can be life-threatening and may affect internal organs. Seek medical help immediately if you experience red, swollen, blistered, or peeling skin; red or irritated eyes; sores in your mouth, throat, nose, eyes, genitals, or skin; fever; chills; body aches; shortness of breath; or swollen glands.

Common Side Effects:

While many people do not experience side effects or only have mild ones, some common side effects include:

Headache
Stomach pain or diarrhea
Gas
* Upset stomach or vomiting

If these or any other side effects bother you or do not go away, contact your doctor or seek medical attention. You can also report side effects to the FDA at 1-800-332-1088 or https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe or persistent diarrhea, especially if watery or bloody (may indicate C. difficile infection)
  • Unexplained weight loss, difficulty swallowing, or painful swallowing (may indicate a more serious underlying condition)
  • Black, tarry stools or vomiting blood/coffee-ground material (signs of gastrointestinal bleeding)
  • Muscle cramps, spasms, weakness, dizziness, or irregular heartbeat (signs of low magnesium)
  • New or worsening joint pain, rash on cheeks/nose (signs of lupus erythematosus)
  • Signs of kidney problems: changes in urination, swelling in ankles/feet, fatigue, nausea
  • Any new or unusual symptoms.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, including:
+ Bartter's syndrome
+ Low calcium or potassium levels
+ Acid-base problems in the blood
Symptoms of potentially serious health issues, such as:
+ Black or bloody stools
+ Heartburn accompanied by lightheadedness, sweating, dizziness, or wheezing
+ Chest pain
+ Shoulder pain with shortness of breath
+ Pain that radiates to the arms, neck, or shoulders
+ Lightheadedness
+ Excessive sweating
+ Vomiting blood
+ Difficulty or pain when swallowing food
A history of kidney problems caused by this medication or similar drugs
* Use of certain medications, including:
+ Atazanavir
+ Clopidogrel
+ Methotrexate
+ Nelfinavir
+ Rifampin
+ Rilpivirine
+ St. John's wort
+ Warfarin

Please note that this is not an exhaustive list of all potential interactions. It is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist to ensure safe use of this medication. Do not initiate, stop, or modify the dosage of any medication without consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. The full effect of this drug may not be apparent for a few days. Do not exceed the prescribed duration of treatment, as directed by your doctor.

This medication may interfere with certain laboratory tests. Be sure to notify all your healthcare providers and laboratory personnel that you are taking this drug. If you are following a low-sodium or sodium-free diet, consult with your doctor, as some formulations of this medication may contain sodium.

If you have diabetes (high blood sugar), it is crucial to monitor your blood sugar levels closely, as this medication may increase the risk of elevated blood sugar. Additionally, this drug may increase the risk of fractures in the hip, spine, and wrist, particularly in individuals with osteoporosis (weak bones). The risk may be higher if you take this medication in high doses or for an extended period (more than a year), or if you are over 50 years old.

If you have risk factors for osteoporosis, such as a history of alcohol consumption, smoking, steroid use, or seizure medication, or if you have a family history of osteoporosis, exercise caution and discuss your risks with your doctor.

Prolonged use of this medication (at least 3 months) may lead to rare cases of low magnesium levels, often occurring after 1 year of treatment. This condition may cause other electrolyte problems, and your doctor may recommend regular blood tests to monitor your magnesium levels.

In rare instances, this medication has been associated with severe pancreas, liver, and white blood cell problems, which can be fatal. If you have any questions or concerns, consult with your doctor. Long-term use of this medication (more than 1 year) may also increase the risk of stomach growths called fundic gland polyps. If you have questions, discuss them with your doctor.

Individuals of Asian descent should use this medication with caution, as they may be more susceptible to side effects. If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the potential benefits and risks to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Drowsiness
  • Tachycardia
  • Metabolic alkalosis (due to sodium bicarbonate, symptoms include muscle weakness, confusion, irregular heart rhythm)

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is symptomatic and supportive. Monitor electrolytes and acid-base balance.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Rilpivirine (due to significant reduction in rilpivirine exposure)
  • Nelfinavir (due to significant reduction in nelfinavir exposure)
🔴

Major Interactions

  • Clopidogrel (reduced antiplatelet effect)
  • Methotrexate (increased methotrexate levels)
  • Warfarin (increased INR/bleeding risk)
  • Digoxin (increased digoxin levels)
  • Tacrolimus (increased tacrolimus levels)
  • Citalopram (increased citalopram levels, QT prolongation risk)
  • Cilostazol (increased cilostazol levels)
  • Diazepam (increased diazepam levels)
  • Phenytoin (increased phenytoin levels)
  • Saquinavir (reduced saquinavir levels)
  • Iron salts (reduced absorption of iron)
  • Mycophenolate mofetil (reduced mycophenolic acid exposure)
  • Drugs requiring acidic gastric pH for absorption (e.g., ketoconazole, itraconazole, atazanavir, erlotinib, nelfinavir, rilpivirine, dasatinib, nilotinib, pazopanib, posaconazole, iron salts)
🟡

Moderate Interactions

  • Voriconazole (increased omeprazole levels)
  • St. John's Wort (decreased omeprazole levels)
  • Dabigatran etexilate (increased dabigatran exposure)
  • Theophylline (potential for increased theophylline levels)
  • Sucralfate (may reduce omeprazole absorption; administer omeprazole at least 30 minutes before sucralfate)
  • Diuretics (increased risk of hypomagnesemia)
  • Drugs that prolong QT interval (additive risk with citalopram)
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Baseline symptoms of GERD/ulcer disease

Rationale: To establish a baseline for symptom improvement and assess treatment efficacy.

Timing: Prior to initiation of therapy

Electrolytes (Magnesium, Calcium, Potassium)

Rationale: To assess baseline levels, especially in patients at risk for electrolyte imbalances or on long-term therapy.

Timing: Prior to initiation of therapy, particularly for long-term use or in patients on diuretics

Renal function (BUN, Creatinine)

Rationale: To assess baseline renal function, especially given sodium bicarbonate component and potential for AIN with PPIs.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Symptom resolution/control

Frequency: Regularly throughout therapy (e.g., weekly for initial treatment, then as needed)

Target: Significant reduction or elimination of symptoms

Action Threshold: Persistent or worsening symptoms may indicate need for dose adjustment, further diagnostic workup, or alternative therapy.

Electrolytes (Magnesium, Calcium, Potassium)

Frequency: Periodically for long-term therapy (e.g., every 3-6 months or annually), or as clinically indicated for patients at risk.

Target: Within normal limits

Action Threshold: Hypomagnesemia, hypocalcemia, or hypokalemia may require supplementation or discontinuation of PPI.

Renal function (BUN, Creatinine)

Frequency: Periodically for long-term therapy (e.g., annually), or if acute kidney injury is suspected.

Target: Within normal limits

Action Threshold: Elevated levels may indicate acute interstitial nephritis or chronic kidney disease, requiring investigation.

Bone mineral density (DEXA scan)

Frequency: Consider for patients on long-term (e.g., >1 year) high-dose therapy, especially with other risk factors for osteoporosis.

Target: Maintain healthy bone density

Action Threshold: Significant bone loss may warrant discontinuation or reduction of PPI, and initiation of bone-protective therapies.

đŸ‘ī¸

Symptom Monitoring

  • Persistent or worsening heartburn
  • Dysphagia (difficulty swallowing)
  • Odynophagia (painful swallowing)
  • Unexplained weight loss
  • Recurrent vomiting
  • Gastrointestinal bleeding (black, tarry stools; coffee-ground emesis)
  • New or worsening diarrhea (especially watery or bloody)
  • Muscle cramps, weakness, tremors, or arrhythmias (signs of hypomagnesemia)
  • Fatigue, pallor, shortness of breath (signs of vitamin B12 deficiency)
  • Signs of kidney problems (changes in urination, swelling, fatigue)

Special Patient Groups

🤰

Pregnancy

Omeprazole is generally considered low risk during pregnancy. Studies in animals have shown no evidence of harm, and human data suggest no increased risk of major birth defects. However, sodium bicarbonate can contribute to fluid retention and metabolic alkalosis, which should be considered. Use only if clearly needed.

Trimester-Specific Risks:

First Trimester: Generally considered low risk for omeprazole. Sodium bicarbonate use should be monitored for fluid and electrolyte balance.
Second Trimester: Generally considered low risk for omeprazole. Sodium bicarbonate use should be monitored for fluid and electrolyte balance.
Third Trimester: Generally considered low risk for omeprazole. Sodium bicarbonate use should be monitored for fluid and electrolyte balance, especially in pre-eclampsia or other conditions with fluid retention.
🤱

Lactation

Omeprazole is excreted into breast milk in small amounts. Sodium bicarbonate is also excreted. While the amount of omeprazole is generally considered too low to cause adverse effects in breastfed infants, caution is advised. The L3 lactation risk rating suggests moderate concern. Monitor infant for any adverse effects (e.g., diarrhea, drowsiness).

Infant Risk: Low to moderate risk. Potential for minor GI upset in infant from omeprazole. Sodium bicarbonate may alter infant's acid-base balance if significant amounts are transferred.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established in pediatric patients under 18 years of age for Zegerid Powder Packets. Omeprazole alone is approved for certain pediatric indications, but the combination with sodium bicarbonate is not.

👴

Geriatric Use

No overall differences in safety or effectiveness were observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dosage adjustment for omeprazole is generally not needed based on age alone. However, elderly patients may be more susceptible to adverse effects of sodium bicarbonate (e.g., fluid overload, metabolic alkalosis) and long-term PPI risks (e.g., bone fractures, C. difficile infection, hypomagnesemia). Use with caution and monitor closely.

Clinical Information

💎

Clinical Pearls

  • Zegerid's sodium bicarbonate component provides immediate acid neutralization and protects omeprazole from degradation, allowing for faster and more consistent absorption compared to delayed-release omeprazole formulations.
  • Always take Zegerid on an empty stomach, at least 30-60 minutes before a meal, for optimal efficacy.
  • Long-term use of PPIs (including Zegerid) has been associated with increased risks of C. difficile infection, bone fractures (hip, wrist, spine), hypomagnesemia, vitamin B12 deficiency, and acute interstitial nephritis. Periodically reassess the need for continued therapy.
  • The sodium bicarbonate component can be problematic in patients with renal impairment, heart failure, or those on sodium-restricted diets due to its sodium content and potential for metabolic alkalosis.
  • Be aware of significant drug interactions, especially with clopidogrel, methotrexate, and certain antiretrovirals, due to omeprazole's CYP2C19 inhibition and gastric pH alteration.
🔄

Alternative Therapies

  • Other Proton Pump Inhibitors (PPIs): Esomeprazole (Nexium), Lansoprazole (Prevacid), Pantoprazole (Protonix), Rabeprazole (Aciphex), Dexlansoprazole (Dexilant)
  • H2-receptor antagonists (H2RAs): Famotidine (Pepcid), Ranitidine (Zantac - withdrawn in some regions), Cimetidine (Tagamet), Nizatidine (Axid)
  • Antacids (e.g., calcium carbonate, aluminum hydroxide/magnesium hydroxide)
  • Prokinetics (e.g., metoclopramide - for specific motility disorders)
  • Surgery (e.g., Nissen fundoplication for severe GERD)
💰

Cost & Coverage

Average Cost: Varies widely, typically $100-$500+ per 30 packets
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Brand), Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure your safety, never share your medication with others or take someone else's medication. This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information. Please read this guide carefully and review it each time you receive a refill of this medication. If you have any questions or concerns about this medication, do not hesitate to consult with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.